Bicara Therapeutics Inc. 10-Q filing
Filed 2025-11-10 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0002023658-25-000109
- Form type
- 10-Q
- CIK
- 0002023658
- Primary document
- https://www.sec.gov/Archives/edgar/data/2023658/000202365825000109/bcax-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Bicara Therapeutics Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-114.5M | - | - |
| Net Income | $-100.6M | - | - |
| Eps Basic | -1.84 | - | - |
| Eps Diluted | -1.84 | - | - |
| Cash And Equivalents | $171.7M | - | - |
| Total Assets | $424.7M | - | - |
| Total Liabilities | $21.9M | - | - |
| Shareholders Equity | $402.8M | - | - |
| Operating Cash Flow | $-82.9M | - | - |
| Capital Expenditures | $42,000 | - | - |